1-4 of 4
Michal Besser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study

Ana Alarcon Tomas, Joshua A Fein, Shalev Fried, Warren Fingrut, Theodora Anagnostou, Anna Alperovich, Nishi Shah, Ellen Fraint, Richard J Lin, Michael Scordo, Aishat Olaide Afuye, Connie Lee Batlevi, Michal Besser, Parastoo B Dahi, Ivetta Danylesko, Sergio Giralt, Brandon S. Imber, Elad Jacobi, Arnon Nagler, M. Lia Palomba, Gilles Salles, Craig S. Sauter, Gunjan L Shah, Noga Shem-Tov, Avichai Shimoni, Joachim Yahalom, Ronit Yerushalmi, Abraham Avigdor, Miguel-Angel Perales, Roni Shouval
Journal: Blood
Blood (2021) 138 (Supplement 1): 883.
https://doi.org/10.1182/blood-2021-147568
Published: 2021
Journal Articles

Encouraging Survival and High Rates of Toxicity: Allogeneic Hematopoietic Cell Transplantation after Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Aggressive Lymphoma Patients

Shalev Fried, Ivetta Danylesko, Ronit Yerushalmi, Noga Shem-Tov, Roni Shouval, Joshua A Fein, Zachary Cohen, Elad Jacoby, Michal Besser, Arnon Nagler, Avichai Shimoni, Abraham Avigdor
Journal: Blood
Blood (2021) 138 (Supplement 1): 910.
https://doi.org/10.1182/blood-2021-147148
Published: 2021
Journal Articles

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Ohad Benjamini, Avichai Shimoni, MD, Michal Besser, PhD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Drorit Grizim Merkel, MD, Tamar Tadmor, MD, David Lavie, MD, Riva Fineman, MD, Elad Jacobi, MD, Arnon Nagler, MD, Abraham Avigdor, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40.
https://doi.org/10.1182/blood-2020-138904
Published: 2020
Journal Articles

The Efficacy and Safety of Anti-CD19 CAR T-Cell Therapy in Young Adults with Relapsed and Refractory Aggressive B-Cell Malignancies—the Experience of a Single Center in Israel

Abraham Avigdor, MD, Michal Besser, PhD, Arnon Nagler, MD, Orit Itzhaki, PhD, Jacob Schachter, MD, Avichai Shimoni, MD, Ronit Yerushalmi, MD, Amos Toren, MD PhD, Elad Jacobi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5206.
https://doi.org/10.1182/blood.V130.Suppl_1.5206.5206
Published: 2017